radiopharmaceuticals

Graphic image of a red thumbs down against a blue background

ITM cancer drug spurned by FDA over manufacturing qualms

The problems lie not with ITM-11's efficacy or safety but with its CMC and with a third-party commercial facility.

Darren Incorvaia Aug 10, 2026 11:25am

Fierce Biotech

Curium strikes up to $8B deal for radiopharma rival Lantheus

Aug 3, 2026 2:20pm

NVS

Novartis' Pluvicto unlocks substantial new patient pool

Aug 3, 2026 8:33am

Downtown Boston with a famous historical building center frame and surrounded by tall modern skyscrapers

AdvanCell inks lease for US radiopharmaceutical production, HQ

Jun 24, 2026 8:40am

cancer target detection radiopharma radio

Lantheus considers potential $7B Curium buyout proposal: report

May 26, 2026 10:38am

Niowave

Niowave starts building $75M plant to boost radioisotope supply

May 26, 2026 8:35am